Skip to main content

Frail Elderly Syndrome

0
Pipeline Programs
3
Companies
5
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Presage Biosciences
3 programs
PRESAE CAREN/A1 trial
PRESAGE CAREN/A1 trial
Presage careN/A1 trial
Active Trials
NCT06013709Completed1,478Est. Dec 2022
NCT06018532Unknown100Est. Jul 2024
NCT06019390Unknown200Est. Jul 2024
City Therapeutics
City TherapeuticsMA - Cambridge
1 program
The Prediction Model of Elderly Patients in Taiwan Triage and Acuity ScaleN/A1 trial
Active Trials
NCT04862936UnknownEst. Jul 2021
Eppendorf
EppendorfGermany - Hamburg
1 program
Unsupervised home-based physical prehabilitationN/A1 trial
Active Trials
NCT03964363Completed512Est. Oct 2024

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Presage BiosciencesPRESAGE CARE
Presage BiosciencesPresage care
City TherapeuticsThe Prediction Model of Elderly Patients in Taiwan Triage and Acuity Scale
EppendorfUnsupervised home-based physical prehabilitation
Presage BiosciencesPRESAE CARE

Clinical Trials (5)

Total enrollment: 2,290 patients across 5 trials

NCT06018532Presage BiosciencesPRESAGE CARE

Medical Monitoring of Older Adults Patients After Discharged From Heart Failure Hospitalization

Start: Dec 2023Est. completion: Jul 2024100 patients
N/AUnknown
NCT06019390Presage BiosciencesPresage care

eHealth for Screening Health Risks in Home-Based Older Adults: A Prospective Study

Start: Oct 2023Est. completion: Jul 2024200 patients
N/AUnknown
NCT04862936City TherapeuticsThe Prediction Model of Elderly Patients in Taiwan Triage and Acuity Scale

The Prediction Model of Elderly Patients in Taiwan Triage and Acuity Scale

Start: Jan 2020Est. completion: Jul 2021
N/AUnknown
NCT03964363EppendorfUnsupervised home-based physical prehabilitation

Home-based Prehabilitation for Elderly Patients

Start: May 2019Est. completion: Oct 2024512 patients
N/ACompleted
NCT06013709Presage BiosciencesPRESAE CARE

A Machine Learning Algorithm to Predict Health Clinical Situations in Primary Healthcare for Frail Older Adults.

Start: Apr 2016Est. completion: Dec 20221,478 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.